These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26561906)

  • 21. Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia.
    Banks E; Crouch SR; Korda RJ; Stavreski B; Page K; Thurber KA; Grenfell R
    Med J Aust; 2016 May; 204(8):320. PubMed ID: 27125809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent discontinuation rates in patients prescribed lipid-lowering drugs.
    Simons LA; Levis G; Simons J
    Med J Aust; 1996 Feb; 164(4):208-11. PubMed ID: 8604188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving organisational systems for diabetes care in Australian Indigenous communities.
    Bailie R; Si D; Dowden M; O'Donoghue L; Connors C; Robinson G; Cunningham J; Weeramanthri T
    BMC Health Serv Res; 2007 May; 7():67. PubMed ID: 17480239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
    Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
    Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. General practice encounters with Aboriginal and Torres Strait Islander people.
    Zhang C; Valenti L; Britt H
    Aust Fam Physician; 2014; 43(1):15. PubMed ID: 24563886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Whiplash Associated Disorders in Australian general practice.
    Nikles J; Yelland M; Bayram C; Miller G; Sterling M
    BMC Musculoskelet Disord; 2017 Dec; 18(1):551. PubMed ID: 29284446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting general practitioners' decisions to adopt new prescription drugs - cohort analyses using Australian longitudinal physician survey data.
    Zhang Y; Méndez SJ; Scott A
    BMC Health Serv Res; 2019 Feb; 19(1):94. PubMed ID: 30728010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Hypertension and High Low-Density Lipoprotein in Pediatric Type 1 Diabetes.
    Katz ML; Guo Z; Laffel LM
    J Pediatr; 2018 Jun; 197():140-146.e12. PubMed ID: 29395184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of primary health care service use of Indigenous Australians diagnosed with cancer.
    Valery PC; Bernardes CM; de Witt A; Martin J; Walpole E; Garvey G; Williamson D; Meiklejohn J; Hartel G; Ratnasekera IU; Bailie R
    Support Care Cancer; 2020 Jan; 28(1):317-327. PubMed ID: 31049670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Encounters with indigenous patients in Australian general practice.
    Charles J; Britt H; Knox S
    Aust Fam Physician; 2005 Oct; 34(10):810-1. PubMed ID: 16217563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescribing for comorbid disease in a palliative population: focus on the use of lipid-lowering medications.
    Russell BJ; Rowett D; Abernethy AP; Currow DC
    Intern Med J; 2014 Feb; 44(2):177-84. PubMed ID: 24341863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospitalizations for Chronic Conditions Among Indigenous Australians After Medication Copayment Reductions: the Closing the Gap Copayment Incentive.
    Trivedi AN; Bailie R; Bailie J; Brown A; Kelaher M
    J Gen Intern Med; 2017 May; 32(5):501-507. PubMed ID: 27798778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing early career general practitioners' antibiotic prescribing for respiratory tract infections: a pragmatic prospective non-randomised controlled trial.
    Magin P; Tapley A; Morgan S; Davis JS; McElduff P; Yardley L; Henderson K; Dallas A; McArthur L; Mulquiney K; Davey A; Little P; Spike N; van Driel ML
    Fam Pract; 2018 Jan; 35(1):53-60. PubMed ID: 28985369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing for people with type 2 diabetes and renal impairment in Australian general practice: A national cross sectional study.
    Manski-Nankervis JE; Thuraisingam S; Sluggett JK; Lau P; Blackberry I; Ilomaki J; Furler J; Bell JS
    Prim Care Diabetes; 2019 Apr; 13(2):113-121. PubMed ID: 30262176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription patterns of lipid lowering agents among older patients in general practice: an analysis from a national database in the Netherlands.
    Kleipool EEF; Nielen MMJ; Korevaar JC; Harskamp RE; Smulders YM; Serné E; Thijs A; Peters MJL; Muller M
    Age Ageing; 2019 Jul; 48(4):577-582. PubMed ID: 31074492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overprescribing of lipid lowering agents.
    Smith MA; Cox ED; Bartell JM
    Qual Saf Health Care; 2006 Aug; 15(4):251-7. PubMed ID: 16885249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administrative encounters in general practice: low value or hidden value care?
    Trevena LJ; Harrison C; Britt HC
    Med J Aust; 2018 Feb; 208(3):114-118. PubMed ID: 29438646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepine-opioid co-prescribing in a national probability sample of ED encounters.
    Kim HS; McCarthy DM; Mark Courtney D; Lank PM; Lambert BL
    Am J Emerg Med; 2017 Mar; 35(3):458-464. PubMed ID: 27923527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues with prescribed medications in Aboriginal communities: Aboriginal health workers' perspectives.
    Hamrosi K; Taylor SJ; Aslani P
    Rural Remote Health; 2006; 6(2):557. PubMed ID: 16683907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.